Search

Your search keyword '"Svegliati, Baroni Gianluca"' showing total 478 results

Search Constraints

Start Over You searched for: Author "Svegliati, Baroni Gianluca" Remove constraint Author: "Svegliati, Baroni Gianluca"
478 results on '"Svegliati, Baroni Gianluca"'

Search Results

3. Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study

4. Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care

5. Hypoalbuminemia and Risk of Portal Vein Thrombosis in Cirrhosis

7. Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma

8. Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease

9. A global research priority agenda to advance public health responses to fatty liver disease

10. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs

11. THU-161 Hepatic sarcoidosis diagnosis and management: an italian multicenter study

12. THU-472-YI Sorafenib as a second-line treatment after failure of Atezolizumab/Bevacizumab

13. WED-293 Effectiveness of on different models of care based on Fibrosis-4 and/or liver stiffness measurement for the screening of patients with type 2 diabetes mellitus at risk of advanced liver disease

14. SAT-477-YI The impact of etiologyon patterns of progression of advanced HCC

15. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

17. Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)

18. Global prevalence of MAFLD-related hepatocellular carcinoma: A systematic review and meta-analysis

19. Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University

21. Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma.

22. Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial

23. List of contributors

25. Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements

28. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs

29. The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients

30. Prophylaxis of HBV-recurrence after liver transplantation in patients with HCC: risk of HCC recurrence from a large, multicentre retrospective study from Italy

31. Primary sclerosing cholangitis recurrence after liver transplantation: a nationwide survey in Italy

32. Presence and severity of esophageal varices drives portal hypertension-related complications in compensated advanced non-alcoholic fatty liver disease

33. Further decompensation as a new prognostic stage in cirrhosis. Results of a large multicenter cohort study supporting Baveno VII statements

34. Burden of non-alcoholic fatty liver disease and usefulness of non-invasive tests to identify advanced liver disease in patients with type 2 diabetes mellitus: interim analysis of an Italian prospective multicentre study

36. Predictors of non‐transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection.

37. Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group

39. Corrigendum to ‘Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)’ Nutrition, Metabolism and Cardiovascular diseases volume 32 issue 1 (2022) 1-16

40. Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease

41. Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma

44. Corrigendum to “Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)” [Dig Liver Dis 54 (2022) 170–182]

45. Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study

46. Clinical Presentation, Risk Factors and Outcome of Splanchnic Venous Thrombosis: A Report on 305 Cases

47. Combination Treatment with Hydroxytyrosol and Vitamin E Improves NAFLD-Related Fibrosis

48. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

49. Monofocal hepatocellular carcinoma: How much does size matter?

Catalog

Books, media, physical & digital resources